S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61

ICC Labs Stock Forecast, Price & News

-0.10 (-5.81%)
(As of 11/26/2018)
Today's Range
50-Day Range
52-Week Range
646,156 shs
Average Volume
799,310 shs
Market Capitalization
C$223.63 million
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive ICC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICC Labs and its competitors with MarketBeat's FREE daily newsletter.

ICC Stock Forecast (MarketRank)

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
ICC Labs logo

About ICC Labs (CVE:ICC)

ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.

ICC Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Drug Manufacturers - Specialty & Generic
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
C$533.68 thousand
Cash Flow
C$0.06 per share
Book Value
C$0.29 per share


Free Float
Market Cap
C$223.63 million
Not Optionable

ICC Labs Frequently Asked Questions

How has ICC Labs' stock performed in 2022?

ICC Labs' stock was trading at C$1.62 at the start of the year. Since then, ICC shares have increased by 0.0% and is now trading at C$1.62.
View the best growth stocks for 2022 here

Who are ICC Labs' key executives?

ICC Labs' management team includes the following people:
  • Mr. Alejandro Antalich, Chief Exec. Officer
  • Mr. Oscar Alejandro Leon, Chief Financial Officer
  • Mr. Diego Taranto, Sr. Financial Controller

What other stocks do shareholders of ICC Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICC Labs investors own include Aphria (APHA), Canopy Growth (WEED), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Emblem (EMC), Medical Marijuana (MJNA), WeedMD (WMD), (XXII), Cannabix Technologies (BLO) and Auxly Cannabis Group (CBWTF).

What is ICC Labs' stock symbol?

ICC Labs trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICC."

How do I buy shares of ICC Labs?

Shares of ICC and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ICC Labs' stock price today?

One share of ICC stock can currently be purchased for approximately C$1.62.

How much money does ICC Labs make?

ICC Labs (CVE:ICC) has a market capitalization of C$223.63 million and generates C$533.68 thousand in revenue each year.

How can I contact ICC Labs?

ICC Labs' mailing address is 595 Burrard Street Suite 700 Stn Bentall Centre PO Box 49290, VANCOUVER, BC V7X 1S8, Canada. The official website for ICC Labs is www.intcannabiscorp.com. The company can be reached via phone at +1-604-6892646.

This page (CVE:ICC) was last updated on 6/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.